BioCentury
ARTICLE | Clinical News

CPP-115: Phase Ia started

January 2, 2012 8:00 AM UTC

Catalyst began a double-blind, placebo-controlled, single ascending-dose U.S. Phase Ia trial to evaluate CPP-115 in about 48 healthy volunteers. ...